Together with our previous studies indicating that DJ4 has potential therapeutic efficacy in mouse models of AML, we determined that targeting the ROCK1/2 and MRCK α/β kinase simultaneously is an effective strategy to reduce migration of highly invasive/metastatic cancers and induce cancer cell death. The gene discussed is ROCK1; the disease is acute myeloid leukemia.